Kraig Biocraft Laboratories, Inc.
KBLB
$0.14
$0.001.05%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -54.10% | 148.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -49.60% | 124.85% | |||
| Operating Income | 49.60% | -124.85% | |||
| Income Before Tax | 47.83% | -107.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 47.83% | -107.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 47.83% | -107.91% | |||
| EBIT | 49.60% | -124.85% | |||
| EBITDA | 49.92% | -125.97% | |||
| EPS Basic | 50.00% | -100.00% | |||
| Normalized Basic EPS | 44.44% | -80.00% | |||
| EPS Diluted | 50.00% | -100.00% | |||
| Normalized Diluted EPS | 44.44% | -80.00% | |||
| Average Basic Shares Outstanding | 1.14% | 1.98% | |||
| Average Diluted Shares Outstanding | 1.14% | 1.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||